Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
UK patients with type II diabetes have gained another treatment option for improving blood glucose levels with the launch of AstraZeneca's Xigduo this week.
Xigduo combines diabetes therapies Forxiga (dapagliflozin) and metformin in a twice-daily tablet, indicated for use in patients inadequately controlled on their current metformin-based treatment regimen, or who are currently being treated with the combination of dapagliflozin and metformin as separate tablets.
http://www.pharmatimes.com/Article/14-03-11/AZ_rolls_out_diabetes_combo_Xigduo_across_UK.aspx
Xigduo combines diabetes therapies Forxiga (dapagliflozin) and metformin in a twice-daily tablet, indicated for use in patients inadequately controlled on their current metformin-based treatment regimen, or who are currently being treated with the combination of dapagliflozin and metformin as separate tablets.
http://www.pharmatimes.com/Article/14-03-11/AZ_rolls_out_diabetes_combo_Xigduo_across_UK.aspx